Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « Outcome Assessment, Health Care »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Osteosclerosis < Outcome Assessment, Health Care < Ovarian Hyperstimulation Syndrome  Facettes :

List of bibliographic references indexed by Outcome Assessment, Health Care

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]
Ident.Authors (with country if any)Title
000813 (2019) Sara Monti [Italie] ; Ana F. Águeda [Portugal] ; Raashid Ahmed Luqmani [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Maria Cid [Espagne] ; Christian Dejaco [Italie, Autriche] ; Alfred Mahr [France] ; Cristina Ponte [Portugal] ; Carlo Salvarani [Italie] ; Wolfgang Schmidt [Allemagne] ; Bernhard Hellmich [Allemagne]Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis
000E47 (2019) Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Elodie Perrodeau [France] ; Thomas Bardin [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; Rene-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Arnaud Constantin [France] ; Philippe Ravaud [France] ; Xavier Mariette [France]Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study
000F89 (2019) François Vercruysse [France] ; Thomas Barnetche [France] ; Estibaliz Lazaro [France] ; Emilie Shipley [France] ; François Lifermann [France] ; Alexandre Balageas [France] ; Xavier Delbrel [France] ; Bruno Fautrel [France] ; Christophe Richez [France] ; Thierry Schaeverbeke [France] ; Marie-Elise Truchetet [France]Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy
001099 (2018) Francesco Muratore [Italie] ; Giulia Pazzola [Italie] ; Alessandra Soriano [Italie] ; Nicol Pipitone [Italie] ; Stefania Croci [Italie] ; Martina Bonacini [Italie] ; Luigi Boiardi [Italie] ; Carlo Salvarani [Italie]Unmet Needs in the Pathogenesis and Treatment of Vasculitides.
001707 (2017) Takayuki Katsuyama [Japon] ; Ken-Ei Sada [Japon] ; Minglu Yan [Japon] ; Sonia Zeggar [Japon] ; Sumie Hiramatsu [Japon] ; Yoshia Miyawaki [Japon] ; Keiji Ohashi [Japon] ; Michiko Morishita [Japon] ; Haruki Watanabe [Japon] ; Eri Katsuyama [Japon] ; Mariko Takano-Narazaki [Japon] ; Noriko Toyota-Tatebe [Japon] ; Katsue Sunahori-Watanabe [Japon] ; Tomoko Kawabata [Japon] ; Kohei Miyake [Japon] ; Toru Kiguchi ; Jun Wada [Japon]Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
001784 (2017) Anagha Nadkarni [États-Unis] ; Donna Mcmorrow [États-Unis] ; Chad Patel [États-Unis] ; Robert Fowler [États-Unis] ; David Smith [États-Unis]Incidence of dose escalation and impact on biologic costs among patients with rheumatoid arthritis treated with three intravenous agents.
001901 (2017) Jessica M. Franklin [États-Unis] ; Sebastian Schneeweiss [États-Unis] ; Daniel H. Solomon [États-Unis]Assessment of Confounders in Comparative Effectiveness Studies From Secondary Databases.
001926 (2017) Jin Nakagawa [Japon] ; Yoshinobu Koyama [Japon] ; Atsushi Kawakami [Japon] ; Yukitaka Ueki [Japon] ; Hiroshi Tsukamoto [Japon] ; Takahiko Horiuchi [Japon] ; Shuji Nagano [Japon] ; Ayumi Uchino [Japon] ; Toshiyuki Ota [Japon] ; Mitsuteru Akahoshi [Japon] ; Koichi Akashi [Japon]A novel scoring system based on common laboratory tests predicts the efficacy of TNF-inhibitor and IL-6 targeted therapy in patients with rheumatoid arthritis: a retrospective, multicenter observational study.
001E18 (2015) A. Rubbert-Roth [Allemagne][Switching within the active ingredient group or changing the mechanism of action. Data situation by failure of the first line biologic].
001F47 (2015) Ivan Foeldvari [Allemagne]Ocular Involvement in Juvenile Idiopathic Arthritis: Classification and Treatment.
002356 (2014) Nicolás González-Vacarezza ; Alicia Alemán ; Graciela González ; Ana PérezRituximab and tocilizumab for the treatment of rheumatoid arthritis.
002392 (2014) Tamarah D. De Jong ; Saskia Vosslamber ; Cornelis L. VerweijMoving towards personalized medicine in rheumatoid arthritis.
003521 (2012) E J Soini [Finlande] ; T A Hallinen ; K. Puolakka ; V. Vihervaara ; M J KauppiCost-effectiveness of adalimumab, etanercept, and tocilizumab as first-line treatments for moderate-to-severe rheumatoid arthritis.
003526 (2012) Allan Gibofsky [États-Unis]Comparative effectiveness of current treatments for rheumatoid arthritis.
003730 (2012) Yee Chiu [Royaume-Uni] ; Andrew J. K. Ostor [Royaume-Uni] ; Anthony Hammond [Royaume-Uni] ; Katharina Sokoll [Royaume-Uni] ; Marina Anderson [Royaume-Uni] ; Maya Buch [Royaume-Uni] ; Michael R. Ehrenstein [Royaume-Uni] ; Patrick Gordon [Royaume-Uni] ; Sophia Steer [Royaume-Uni] ; Ian N. Bruce [Royaume-Uni]Access to the next wave of biologic therapies (Abatacept and Tocilizumab) for the treatment of rheumatoid arthritis in England and Wales
003815 (2012) Christophe Richez [France] ; Thomas Barnetche ; Liliane Khoryati ; Pierre Duffau ; Marie Kostine ; Cécile Contin-Bordes ; Patrick Blanco ; Thierry SchaeverbekeTocilizumab Treatment Decreases Circulating Myeloid Dendritic Cells and Monocytes, 2 Components of the Myeloid Lineage
003904 (2011) Michael Seitz [Suisse] ; Stephan Reichenbach ; Harald M. Bonel ; Sabine Adler ; Felix Wermelinger ; Peter M. VilligerRapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series.
003978 (2011) Patricia Guyot [Pays-Bas] ; Peter Taylor [Royaume-Uni] ; Robin Christensen [Danemark] ; Louisa Pericleous [Royaume-Uni] ; Coralie Poncet [France] ; Maximilian Lebmeier [Royaume-Uni] ; Pieter Drost [Belgique] ; Gert Bergman [Pays-Bas]Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis
003A64 (2011) Susumu Nishiyama [Japon] ; Tetsushi Aita [Japon] ; Yasuhiko Yoshinaga [Japon] ; Hiroki Kishimoto [Japon] ; Michio Toda [Japon] ; Yoshiki Yoshihara [Japon] ; Shinya Miyoshi [Japon] ; Akira Manki [Japon] ; Shoji Miyawaki [Japon]Proposing a method of regional assessment and a novel outcome measure in rheumatoid arthritis
004011 (2009) Yasuhiko Hirabayashi [Japon] ; Tomonori Ishii [Japon] ; Hideo Harigae [Japon]Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice
004301 (????) Javier Loricera [Espagne] ; Ricardo Blanco ; Santos Casta Eda ; Alicia Humbría ; Norberto Ortego-Centeno ; Javier Narváez ; Cristina Mata ; Sheila Melchor ; Elena Aurrecoechea ; Jaime Calvo-Alén ; Pau Lluch ; Concepci N Moll ; Mauricio Mínguez ; Gabriel Herrero-Beaumont ; Beatriz Bravo ; Esteban Rubio ; Mercedes Freire ; Enriqueta Peir ; Carmen González-Vela ; Javier Rueda-Gotor ; Trinitario Pina ; Natalia Palmou-Fontana ; Vanesa Calvo-Río ; Francisco Ortiz-Sanjuán ; Miguel Ngel González-GayTocilizumab in refractory aortitis: study on 16 patients and literature review.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Outcome Assessment, Health Care" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Outcome Assessment, Health Care" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Outcome Assessment, Health Care
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021